Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation for proceeds of approximately $1.0 billion
Approximately $0.8 billion sold pursuant to Rule 144 along with a concurrent share repurchase by AmerisourceBergen of approximately $0.2 billion
Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and the funding of the company’s strategic priorities, including the definitive agreement for VillageMD to acquire Summit Health-CityMD
No change to ongoing collaboration and long-term strategic partnership
DEERFIELD, Ill., December 09, 2022--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of AmerisourceBergen Corporation (NYSE: ABC) common stock pursuant to Rule 144 for proceeds of approximately $0.8 billion and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by AmerisourceBergen for proceeds of approximately $0.2 billion.
Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock has decreased from approximately 20 percent to approximately 17 percent.
Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and the funding of the company’s strategic priorities, including the definitive agreement for VillageMD to acquire Summit Health-CityMD.
The sale has no impact to the long-term partnership between the two companies. Walgreens Boots Alliance remains fully committed to the strategic, mutually beneficial relationship with AmerisourceBergen, which has been a strong and trusted partner since 2013. Chief Operating Officer, International of Walgreens Boots Alliance, Ornella Barra, will continue to serve on AmerisourceBergen’s Board of Directors.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.
A trusted, global innovator in retail pharmacy with approximately 13,000 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 325,000 people and has a presence in nine countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.
The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: the company is an index component of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Best Corporate Citizens 2022.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221208006102/en/
WBA Media Relations
USA / Jim Cohn, +1 224 813 9057
International, +44 (0)20 7980 8585
WBA Investor Relations
Tiffany Kanaga, +1 847 315 2922